Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: CEL-SCI Corporation (NYSEMKT:CVM), Santarus, Inc.(NASDAQ:SNTS), Zogenix, Inc.(NASDAQ:ZGNX), Align Technology, Inc.(NASDAQ:ALGN)
CEL-SCI Corporation (NYSEMKT:CVM) managed to keep its loss at -9.02% on above-normal volume of 1.62M shares. The stock settled at $1.21 after floating in a range of $1.01 to $1.40. Its latest price has reached market capitalization of $37.50M. Its 52-week range has been $0.18 to $3.90. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Is CVM Ready To Move Up? Find Out Here
Santarus, Inc.(NASDAQ:SNTS) traded on a volume of 1.60M Shares, lower than its standard daily volume. Shares have closed at $22.39. Over the last twelve months, the stock has gained 103.92% and faced a worst price of $8.47. Santarus, Inc. (Santarus) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists.
Is SNTS a Solid Investment at These Levels? Read This Report for Details
Zogenix, Inc.(NASDAQ:ZGNX) settled up at $2.53 on above-normal volume of 1.53M shares during the last trading day. The stock has its 12-month high at $3.30 and 52-week low price was $1.11. It traded in a range of $2.40 to $2.59 during the last trading day. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.
Is ZGNX a Solid Investment at These Levels? Just Go Here and Find Out
In the last trading session, Align Technology, Inc.(NASDAQ:ALGN) was on high volume, trading at a volume of 1.56M versus its average daily volume of 522,212 shares. At $45.80, the stock has attained market capitalization of 3.66B. Align Technology, Inc (Align), designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics, and dental records storage.
Will Investors Buy ALGN After Reading This News? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)